CCEL - CRYO CELL INTERNATIONAL INC

3.24
-0.035   -1.080%

Share volume: 12,299
Last Updated: 03-06-2026
Healthcare/Services – Health: -0.05%

PREVIOUS CLOSE
CHG
CHG%
$3.28
-0.03
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
60%
Profitability 63%
Dept financing 43%
Liquidity 8%
Performance 73%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.22%
1 Month
-3.86%
3 Months
-20.08%
6 Months
-25.00%
1 Year
-54.83%
2 Year
-46.89%
Key data
Stock price
$3.24
P/E Ratio 
0.00
DAY RANGE
$3.21 - $3.24
EPS 
-$0.07
52 WEEK RANGE
$3.10 - $7.70
52 WEEK CHANGE
-$50.15
MARKET CAP 
37.869 M
YIELD 
13.83%
SHARES OUTSTANDING 
8.055 M
DIVIDEND
$0.25
EX-DIVIDEND DATE
02-14-2025
NEXT EARNINGS DATE
N/A
BETA 
0.42
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$6,667
AVERAGE 30 VOLUME 
$13,356
Company detail
CEO: David I. Portnoy
Region: US
Website: cryo-cell.com
Employees: 90
IPO year: 2007
Issue type: Common Stock
Market: NYSE American
Industry: Healthcare/Services – Health
Sector: Services

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells. The company also manufactures and sells PrepaCyte CB processing system. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide.

Recent news